M6PR and neoplasm: Paclitaxel, cisplatin, and doxorubicin treatment rendered tumor cells more sensitive to CTL killing by upregulating mannose-6-phosphate receptors (M6PR) on the tumor cell surface, which augments cell membrane permeability to granzyme B (87).